|
|
Lilly Corporate Center
Indianapolis, Indiana 46285 USA
phone:317-276-2000
fax:+1-317-276-4878
|
|
| Symbol |
LLY |
| Exchange |
NYSE |
| Founded |
1876 |
| Employees |
46100 |
|
|
| www.lilly.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Pharma company based in India |
|
| Management |
| John Lechleiter, Ph.D., Chairman, President and Chief Executive Officer; E. Paul Ahern, Ph.D. Vice President, Global API Manufacturing ; Robert A. Armitage, Senior Vice President and General Counsel; Robert W. Armstrong, Ph.D. Vice President, Global External Research and Development, Lilly Research Laboratories ; Alex M. Azar II, Vice President of Business-to-Business and Puerto Rico for Lilly USA |
| |
|
|
|
|
|
|
|
| Keywords |
| diabetes, severe sepsis, oncology, severe osteoporosis, neuropathic pain |
|
|
|
| Description |
|
Eli Lilly and Company (India) Pvt. Ltd is a subsidiary of the US pharmaceutical major, Eli Lilly and Company. The company was set up in 1993 primarily to manufacture and market a select range of drugs. After its inception in 1993, the Indian operation achieved a quick break-even in 1996. In August 2001, a 100% Lilly subsidiary was created, Eli Lilly and Company (India) Pvt. Ltd. They have 500 employees across India. Product areas include diabetes, oncology, severe osteoporosis, severe sepsis, cardiology and growth hormones |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
